As Chief Executive Officer at Morningside Pharmaceuticals Ltd, Dr Nik Kotecha OBE has utilised his passion for drug discovery and International Trade towards the company’s commitment to “Making Quality Healthcare an Affordable and Accessible Reality Throughout the World”.
Nik started his education at Newcastle, with a First Class Honours Degree in Chemistry; then he went on to do a PhD at Imperial College in London, and finally further Doctorate work at Cambridge University. His areas of research included drug discovery of molecules to treat type II Diabetes and Infection.
Nik draws on his expertise in R&D and worldwide ethnic and cultural diversities gained through visiting most continents, and experience of exporting Healthcare products worldwide. He has a strong passion for giving back to the local community, country and International Aid Sectors.
As a board member of the British Generic Manufacturers Association (BGMA) Nik represents the interests of UK based manufacturers and suppliers of generic medicines and helps to promote the development of the generic medicines industry in the United Kingdom. As well as this, Nik became a Councillor of the CBI East Midlands Regional Council, an Enterprise Forum which represents the voice of business to government.
In the June 2017 Queen’s Birthday Honours Dr Nik Kotecha was truly honoured to be awarded an OBE for services to Entrepreneurship, Innovation in Pharmaceuticals Services and Philanthropy.
Nik enjoys spending time with his wife, two children, other family members and friends. He regularly watches sports games and has a keen interest in economics. Nik also likes to have an active involvement within political affairs.